Keywords: biomarin, alliant, sign, orapred, deal, california, usa-based
BioMarin and Alliant sign Orapred deal
Article | 27 March 2006
California, USA-based drugmaker BioMarin, and Alpharetta, Georgia-headquartered Alliant Pharmaceuticals say they have established a licensing and acquisition agreement covering the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
